AI assistant
JOHNSON & JOHNSON — Director's Dealing 2018
Jul 20, 2018
29750_dirs_2018-07-20_ad7db919-d514-49fe-904f-b70a9dcc1de3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Provention Bio, Inc. (PRVB)
CIK: 0001695357
Period of Report: 2018-07-19
Reporting Person: JOHNSON & JOHNSON (10% Owner)
Reporting Person: Johnson & Johnson Innovation - JJDC, Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-07-19 | Common Stock | C | 2400000 | — | Acquired | 2400000 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-07-19 | Series A Preferred Stock | $ | C | 2400000 | Disposed | Common Stock (2400000) | Indirect |
Footnotes
F1: The Series A Preferred Stock had no expiration date and was automatically converted into shares of Common Stock on a 1-1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering.
F2: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.